ReSHAPE Workshop

5 Dec 2024 | Berlin

Thursday, 5 December 2024 | 13:50 - 14:10

LiveTreg Trial - A Phase I/IIa open label single ascending dose study to assess safety and tolerability of regulatory T cells to promote discontinuation of tacrolimus monotherapy in liver transplant recipients

Format:In-person
  • In vivo engraftment (part 1)